Pharmacotherapy in Aortic Disease
https://libcat.nshealth.ca/en/permalink/provcat39103
Arturo Evangelista, Christoph A. Nienaber, editors.
--Cham:
Springer
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the …
- Available Online
- View e-Book
- Other Authors
- Evangelista, Arturo
- Nienaber, Christoph A
- Responsibility
- Arturo Evangelista, Christoph A. Nienaber, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xii, 269 p. : 31 illus., 23 illus. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9783319095554
- 9783319095547 (print ed.)
- Subjects (MeSH)
- Aortic Diseases - drug therapy
- Abstract
- This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatments that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.
- Contents
- Aortic atherosclerosis as an embolic source -- Aortitis -- Pharmacotherapy of Thoracic Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome: Medical Management -- Medical Treatment in Chronic aortic dissection.
- Format
- e-Book
- Location
- Online
Pharmacological Treatment of Chronic Stable Angina Pectoris
https://libcat.nshealth.ca/en/permalink/provcat39277
Pablo Avanzas, Juan Carlos Kaski, editors.
--Cham:
Springer
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals inclu…
- Available Online
- View e-Book
- Other Authors
- Avanzas, Pablo
- Kaski, Juan Carlos
- Responsibility
- Pablo Avanzas, Juan Carlos Kaski, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xi, 278 p. : 32 illus., 23 illus. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9783319173320
- 9783319173313 (print ed.)
- Subjects (MeSH)
- Adrenergic beta-Antagonists - therapeutic use
- Angina Pectoris - drug therapy
- Cardiovascular Agents - therapeutic use
- Abstract
- This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guide the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
- Contents
- Mechanisms of angina pectoris -- An overview of treatment and guidelines: ESC/ACC-AHA/NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine -- Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
- Format
- e-Book
- Location
- Online
